National guideline concordance and outcomes for pathologic N2 disease in non-small cell lung cancer

BACKGROUND: Real-world treatment practices for positive mediastinal nodal disease in non-small cell lung cancer (NSCLC) continues to vary despite guidelines. We aim to assess national trends in the treatment of pathologic-N2 disease, and evaluate the association with clinical nodal staging and timin...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitzman, Brian, Varghese, Thomas K., Kuchta, Kristine, Krantz, Seth B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186219/
https://www.ncbi.nlm.nih.gov/pubmed/35693597
http://dx.doi.org/10.21037/jtd-21-1845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186219/
https://www.ncbi.nlm.nih.gov/pubmed/35693597
http://dx.doi.org/10.21037/jtd-21-1845

Ejemplares similares